Crime Prevention Council Meets to Balance Privacy and Sharing

2025-19808 — Meeting of the CJIS Advisory Policy Board

The FBI’s CJIS Advisory Policy Board is meeting on December 10-11, 2025, to talk about important updates to crime data and background check systems that affect law enforcement and the public. You can join in person or by phone, and the board will review policies that help keep our justice info safe and up-to-date. No big costs are mentioned, but this meeting shapes how crime data tech moves forward.

2025-07491 — Meeting of the CJIS Advisory Policy Board

The FBI's CJIS Advisory Policy Board is holding a meeting to discuss important updates that affect law enforcement and public safety agencies. They’ll talk about new policies and tech changes that could impact how crime data is shared and protected. This meeting helps make sure everyone stays on the same page and ready for future challenges.

2025-06200 — Notice of Charter Reestablishment

The FBI is bringing back the Criminal Justice Information Services Advisory Policy Board to help guide how criminal justice info systems work. This board includes folks from state, local, tribal, and federal law enforcement, plus judges and other experts. No new costs or deadlines are mentioned, but this move keeps important advice flowing to improve public safety.

2025-05736 — Meeting of the Compact Council for the National Crime Prevention and Privacy Compact

The National Crime Prevention and Privacy Compact Council is having a meeting to discuss how states share crime info while keeping privacy safe. This affects law enforcement and agencies that handle crime data, aiming to improve how info is shared without breaking privacy rules. No big costs or deadlines yet, but stay tuned for updates that could make crime fighting smarter and safer!

2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical

Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.

2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards

Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.

Previous: 2025-19199 — Prospective Grant of an Exclusive Patent License: Substituted Quinoline Analogs As Aldehyde Dehydrogenase 1A1 Inhibitors

The National Institutes of Health is planning to give Stage One Immunotherapeutics an exclusive license to use new inventions that could help fight diseases. This means Stage One gets special rights to develop and sell these cool new medicines, possibly speeding up treatments for patients. Keep an eye out—this move could bring exciting health advances and business opportunities soon!

Next: 2025-19201 — NUREG: Guidelines for Inservice Testing at Nuclear Power Plants-Inservice Testing of Pumps and Valves and Inservice Examination and Testing of Dynamic Restraints (Snubbers) at Nuclear Power Plants

The NRC just updated its guide for checking pumps, valves, and snubbers at nuclear power plants to keep everything safe and running smoothly. This affects plant operators who must follow these clearer, easier-to-understand testing rules. The update helps plants stay on track with inspections, avoiding costly delays or repairs down the line.